There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.
The FDA Drug Labels for naltrexone (PO) do not address this question.
From the Research
Efficacy of Naltrexone
- The efficacy of naltrexone in the treatment of alcohol dependence has been established in several studies 1, 2, 3, 4, 5.
- Oral naltrexone, typically administered at a dose of 50mg, has been shown to reduce relapse and heavy drinking in alcohol-dependent patients 2.
- However, the effectiveness of naltrexone at a dose of 25mg is not explicitly stated in the provided studies.
- Injectable extended-release naltrexone formulations have also been developed to enhance treatment outcome and reduce side effects, but their efficacy compared to oral naltrexone is still being researched 1.
Factors Influencing Efficacy
- The efficacy of naltrexone depends on how it is used, with benefits found when combined with therapy that teaches coping mechanisms, but not when combined with supportive therapy aimed at complete abstinence 3.
- Naltrexone is most effective when administered to patients who are still currently drinking, and when instructions are given to take naltrexone only when drinking is anticipated 3.
- Compliance and persistence with naltrexone treatment are crucial for its effectiveness, and efforts are being made to identify predictors of naltrexone response and to individualize treatment using genetic tools 5.